ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
An International Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression

This study has been completed.
Study NCT00146523.   Last updated on February 22, 2007.   Information provided by Corcept Therapeutics
Please refer to this study by its ClinicalTrials.gov identifier: NCT00146523


Locations
Bulgaria
Svetlozar H Haralanov Ph.D.    
      Sofia, Bulgaria
Luchezar G Hranov M.D.    
      Sofia, Bulgaria
Georgy Koychev M.D.    
      Sofia, Bulgaria
Georgi Popov M.D.    
      Varna, Bulgaria
Vihra Milanova M.D.    
      Sofia, Bulgaria
Croatia
Goran Dodig M.D./Ph.D.    
      Split, Croatia
Pavo Filakovic M.D./Ph.D.    
      Osijek, Croatia
Vera Folnegovic-Smalc M.D./Ph.D.    
      Zagreb, Croatia
Miro Jakovljevic M.D.    
      Zagreb, Croatia
Ljiljana Moro M.D./Ph.D.    
      Rijeka, Croatia
Dubravka Kocijan-Hercigonja M.D.    
      Zagreb, Croatia
Romania
Aurel Nirestean M.D./Ph.D.    
      Targu Mures, Romania
Mihai Dumitru Gheorge    
      Bucharest, Romania
Serbia and Montenegro
Vladimir Diligenski M.D.    
      Belgrade, Serbia and Montenegro
Jelena Martinovic M.D.    
      Belgrade, Serbia and Montenegro
Ratomir Lisulov M.D.    
      Novi Sad, Serbia and Montenegro
Vladimir Paunovic M.D.    
      Belgrade, Serbia and Montenegro
Ivana Timotijevic M.D.    
      Belgrade, Serbia and Montenegro
Dragana Ignjatovic-Ristic M.D.    
      Kragujevac, Serbia and Montenegro

Sponsors and Collaborators
Corcept Therapeutics

Investigators
Study Director:     Katherine Beebe, PhD     Corcept Therapeutics    





Links to all studies - primarily for crawlers